Friday 6 November 2026
Export ENSG’s income statement to Excel — free account
The Ensign Group, Inc.
ENSG Healthcare Medical Care Facilities
The Ensign Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 18.7% from fiscal 2024.
- Revenue
- +14.5%
- EPS
- +23.6%
- Free cash flow
- +89.2%
- Total debt
- +39.2%
Quarter to September 2026, against a year earlier
182.39
5.92
−3.14%
Follow ENSG
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
24.87 | 24.40 | 31.83 | 28.99 |
+8 more quarters Free account |
P/S ratio |
1.75 | 1.69 | 2.21 | 1.97 | |
P/FCF ratio |
19.50 | 22.17 | 28.67 | 26.93 | |
P/Operating CF |
41.40 | 54.03 | 116.23 | 54.46 | |
P/B ratio |
3.88 | 3.80 | 4.91 | 4.47 | |
Price to Tangible BV |
4.04 | 3.97 | 5.14 | 4.69 | |
EV/Sales |
1.72 | 1.66 | 2.12 | 1.89 | |
EV/EBITDA |
15.46 | 15.63 | 20.02 | 18.00 | |
EV/Operating CF |
14.02 | 14.97 | 18.89 | 16.93 | |
EV/FCF |
19.13 | 21.74 | 27.55 | 25.77 | |
Quick Ratio |
1.10 | 1.12 | 1.48 | 1.35 | |
Current Ratio |
1.20 | 1.21 | 1.56 | 1.42 | |
Net Debt/EBITDA |
(1.13) | (1.17) | (2.95) | (2.84) | |
Debt/Assets |
3.31% | 2.43% | 2.51% | 2.59% | |
Debt/Equity |
0.08 | 0.06 | 0.06 | 0.06 | |
Asset Turnover |
1.01 | 1.03 | 1.02 | 1.00 | |
Operating CF/Net income |
2.30 | 1.72 | 1.00 | 1.92 | |
Capex/Depreciation |
(1.44) | (1.67) | (1.22) | (1.78) | |
Interest Coverage |
60.36 | 63.38 | 64.62 | 63.33 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
5.36% | 5.96% | 5.34% | 5.20% | |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.02 | 0.02 | |
Share Based Compensation of Revenue |
1.28% | 1.12% | 1.00% | 0.95% | |
Graham Net Nets |
(0.23) | (0.24) | (0.17) | (0.20) | |
Graham Number |
83.05 | 78.97 | 76.43 | 72.62 | |
Earnings Yield |
4.02% | 4.10% | 3.14% | 3.45% | |
Free Cash Flow Yield |
5.13% | 4.51% | 3.49% | 3.71% | |
Revenue per Share |
25.66 | 24.85 | 24.05 | 23.74 | |
Operating CF per Share |
4.15 | 2.97 | 1.73 | 3.20 | |
Capex per Share |
(0.82) | (0.91) | (0.61) | (0.87) | |
Free Cash Flow per Share |
3.33 | 2.06 | 1.12 | 2.33 | |
Cash per Share |
6.77 | 5.54 | 10.30 | 9.99 | |
Shareholders Equity per Share |
44.33 | 42.19 | 41.02 | 39.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
44.33 | 42.19 | 41.02 | 39.00 | |
Free Cash Flow |
192.63 | 119.13 | 64.68 | 133.48 | |
Working Capital |
191.97 | 186.69 | 472.05 | 377.96 | |
Capital Expenditures |
(47.61) | (52.83) | (35.47) | (49.84) | |
Net Current Asset Value |
(2,280.12) | (2,232.60) | (1,921.96) | (1,955.84) | |
EV/EBIT |
19.15 | 19.49 | 24.93 | 22.46 | |
Capex to Sales |
0.03 | 0.04 | 0.03 | 0.04 | |
Price to Operating Income |
19.53 | 19.88 | 25.94 | 23.47 | |
| Other line items | |||||
Average Receivables |
638.76 | 623.48 | 623.65 | 603.44 | |
Average Payables |
115.59 | 111.24 | 105.73 | 98.14 | |
Average Assets |
5,612.41 | 5,339.84 | 5,185.80 | 5,066.16 | |
Average Common Equity |
2,343.15 | 2,233.15 | 2,149.93 | 2,037.63 |
Columns are period end dates · fundamentals updated 2 Nov 2026